REG - Spectra Systems Spectra Systems-SPSC - Exercise of Options

Spectra SystemsAnnouncement

21/01/2022 07:05

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220121:nRSU1637Za&default-theme=true

RNS Number : 1637Z  Spectra Systems Corporation  21 January 2022

Spectra Systems Corporation

("Spectra" or the "Company")

Exercise of Options

Spectra Systems Corporation, a leader in machine-readable high speed banknote
authentication, brand protection technologies, and gaming security software,
announces the exercise of options by an employee of Spectra.

The employee has exercised options over 20,000 shares of common stock of $0.01
each in the Company ("Shares") with an exercise price of 25p per share. The
employee has elected to utilize the net cashless exercise feature and has
therefore surrendered 3,205 shares to the Company. Accordingly the employee
will be issued 16,795 shares of the Company.

The shares being issued are restricted securities as defined in Rule 144 of
the US Securities Act of 1933 and have been issued pursuant to an exemption
from registration under Rule 701 promulgated under the US Securities Act of
1933.

Accordingly the Company has issued and will apply for 16,795 Shares to be
admitted to trading on AIM, which is expected to take place on or around 26
January 2022 ("Admission").

Following Admission the Company's issued share capital will comprise:

·     1,061,682 shares in the Regulation S stock line ISIN number
USU8457D1091 (AIM:SPSC); and

·   44,258,757 shares in the unrestricted line ISIN number US84756T1060
(AIM:SPSY).

In accordance with the provisions of the Disclosure Guidance and Transparency
Rules of the FCA ("DTRs"), the issued share capital of Spectra upon Admission
is 45,320,439 shares with voting rights attached (one vote per share). There
are no shares held in treasury, therefore this figure may be used by
shareholders as the denominator for the calculation by which they will
determine whether they are required to notify their interest in, or a change
to their interest in, Spectra under the DTRs.

Enquiries:

 

 Spectra Systems Corporation                             Tel: +1 (0)401 274 4700

 Dr. Nabil Lawandy, Chief Executive Officer

 WH Ireland Limited (Nominated Adviser and Broker)       Tel: +44 (0)207 220 1650

 Chris Fielding (Managing Director, Corporate Finance)

 Allenby Capital Limited (Joint Broker)                  Tel: +44 (0)20 3328 5665

 Nick Naylor/James Reeve (Corporate Finance)

 Amrit Nahal (Sales and Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFFFVLLLIIFIF